Search

everythinglearnresearchcommunity

for

Search:↓

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

A group has developed therapies that show promise for treating cancer and various other conditions.

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Belatacept may be a promising treatment for alopecia areata.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Scientists made antibodies to tell cashmere and wool apart, which could improve how we identify animal fibers.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Tridax procumbens plant parts boost immune response in mice.

Topical contact sensitizers can treat certain skin conditions by changing the immune response.

Topical corticosteroids can help treat severe alopecia areata when other treatments fail.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

The patient had a severe allergic reaction to gold treatment.

Cell adhesion molecules are important in the development of certain skin diseases.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Contact immunotherapy helped hair regrow in a patient with both alopecia and psoriasis.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Two men experienced hair regrowth while being treated with immune globulin for other health issues, but there were also side effects.

Upadacitinib improved multiple immune-related conditions in one patient.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.